Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12083164 Amylin analogues

Patent 12083164 was granted and assigned to Zealand Pharma A/S on September, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Zealand Pharma A/S

0

Current Assignee

Zealand Pharma A/S

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Alexander Heim-Riether0

Dieter Wolfgang Hamprecht0

Jesper Mosolff Mathiesen0

Lise Giehm0

Henrik Kofoed Munch0

Giacomo Fossati0

Jesper Skodborg Villadsen0

Date of Patent

September 10, 2024

0

Patent Application Number

173813730

Date Filed

July 21, 2021

0

Patent Citations

US Patent 8741836 Polypeptides

0

US Patent 8895504 Amylin derivatives

0

US Patent 9023789 Amylin analogs and pharmaceutical compositions thereof

0

US Patent 10071140 Amylin analogues

0

US Patent 11382956 Amylin analogues

0

US Patent 10766939 Amylin analogues

0

US Patent 7407934 Methods for regulating postprandial blood glucose

0

US Patent 7910548 Methods for treating obesity

0

...

Patent Primary Examiner

Jeanette M Lieb

0

CPC Code

0

0

Patent abstract

The present invention relates to amylin analogues and to their use in the treatment or prevention of a variety of diseases, conditions or disorders, including obesity, excess food intake and associated metabolic diseases such as diabetes. The analogues have good physical and chemical stability, good solubility, and a long duration of action, and are well suited for use in the form of a liquid formulation.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12083164 Amylin analogues

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool